11C-Harmine as a tracer for monoamine oxidase A (MAO-A): In vitro and in vivo studies

Nuclear Medicine and Biology

Volumn 24, Issue 4, 1997, Pages 287-293

  Bergström, Mats ^a,b   Westerberg, Göran ^a   Långström, Bengt ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Autoradiography; Brain; Clorgyline; Harmine; MAO A; Positron emission tomography

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; BROFAROMINE; CLORGYLINE; ESUPRONE; HARMINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; N (2 AMINOETHYL) 5 (3 FLUOROPHENYL) 4 THIAZOLECARBOXAMIDE; UNCLASSIFIED DRUG; AMINE OXIDASE (FLAVIN CONTAINING);

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN; CONTROLLED STUDY; ENZYME BINDING; MONKEY; POSITRON EMISSION TOMOGRAPHY; ANIMAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ENZYMOLOGY; MACACA; MALE; METABOLISM; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; AUTORADIOGRAPHY; BRAIN; HARMINE; MACACA MULATTA; MALE; MONOAMINE OXIDASE; RATS; RATS, SPRAGUE-DAWLEY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030611043     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(97)00013-9     Document Type: Article

References (16)

1. MacGregor R. R., Fowler J. S., Wolf A. P., Halldin C. and Långström B. (1988) Synthesis of suicide inhibitors of monoamine oxidase: Carbon-11-labelled chlorgyline, L-deprenyl and D-deprenyl. J. Label. Compd. Radiopharm. 25, 1.
2. 11C)deprenyl and dynamic positron emission tomography. J. Cereb. Blood Flow Metab. 11, 545-556.
3. Bench C. J., Price G. W., Lammertsma A. A., Cremer J. C., Luthra et al. (1991) Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): A dose-ranging study with the reversible inhibitor Ro 19-6327. Eur. J. Clin. Pharmacol. 40, 169-173.
4. Fowler J. S., Volkow N. D., Logan J., Schluer D. J. et al. (1993) Monoamine oxidase B (MAO B) inhibitor therapy in Parkinson's disease: The degree and reversibility of human brain MAO B inhibition by Ro 19-6327. Neurology 43, 1984-1992.
5. 11C]-brofaromine, a potential tracer for measuring MAO-A activity with PET. Eur. J. Nucl. Med. 21, 876, (Abstract).
6. 76Br]-brofaromine for PET studies of MAO-A activity. Proceedings of the Eleventh International Symposium on Radiopharmaceutical Chemistry, Vancouver, Canada, pp. 232-233.
7. 11C-labelled MAO-A inhibitors and their in vivo uptake kinetics in rhesus monkey brain. (Submitted for publication).
8. 3H)-labelled ligands visualized by imaging plates. NeuroReport 3, 961-964.
9. 11C)harmine in frozen section autoradiography. Oncol. Rep. 2, 717-721.
10. Kops E. R., Herzog H., Schmid A., Holte S. and Feinendegen L. E. (1990) Performance characteristics of an eight-ring whole body PET scanner. J. Comput. Assist. Tomogr. 14 (3), 437-445.
11. Patlak C. S., Blasberg R. G. and Fenstermacher J. D. (1983) Graphic evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood. Flow Metabol. 3, 1-7.
12. Da Prada M., Kettler R., Keller H. H., Burkard W. P. and Haefely W. E. (1989) Preclinical profiles of the novel reversible MAO-A inhibitors, moclobemide and brofaromine, in comparison with irreversible MAO inhibitors. J. Neural. Transm. Suppl. 28, 5-20.
13. Anderson M. C., Waldmeier P.C. and Tipton K. F. (1991) The inhibition of monoamine oxidase by brofaromine. Biochem. Pharmacol. 41, 1871-1877.
14. 3H)Harman binding experiments: I. A reversible and selective radioligand for monoamine oxidase subtype A in the CNS of the rat. J. Neurochem. 56, 490-499.
15. 3H)Harmaline as a specific ligand of MAO A: I. Properties of the active site of MAO-A from rat and bovine brains. J. Neurochem. 32, 1817-1827.
16. 3H-Ro 19-6327 in vitro: Localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain. J. Neurosci. 12, 1977-1999.